Cornerstone Planning Group
INMB icon

Cornerstone Planning Group’s INmune Bio INMB Stock Holding History

Cornerstone Planning Group’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-304
Closed -$559 – 908
2026
Q2 		$559 Buy
+304
New +$421 ﹤0.01% 1664

Other funds holding INMB

AHL
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
BFA
Bill Few Associates Pittsburgh, Pennsylvania $485M AUM 17.8% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Cornerstone Planning Group's INMB Position: Q3 2026 in Review

Cornerstone Planning Group sold out of INmune Bio (INMB) in Q3 2026, closing a stake of 304 shares — an estimated $559 sold.

Cornerstone Planning Group first reported a position in INMB in Q2 2026 and held it in 1 quarter. The position peaked at $559 in Q2 2026. 6 funds tracked by Wall St. Rank hold INMB as of Q3 2026.

  • Cornerstone Planning Group reported no remaining INmune Bio position as of Q3 2026 after selling out during the quarter.
  • Cornerstone Planning Group sold 304 INmune Bio shares in Q3 2026, an estimated $559.
  • Cornerstone Planning Group first reported a position in INmune Bio in Q2 2026 and held it in 1 quarter.
  • Cornerstone Planning Group's INmune Bio position peaked at $559 in Q2 2026.
  • 6 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.

Based on Cornerstone Planning Group's 13F filing for Q3 2026, filed 16 Oct 2026.